Okazaki, R <br/><br/>
Thiazolidinediones inhibit osteoclast-like cell formation and bone resorption in vitro.  [electronic resource] 

 -  Endocrinology  Nov 1999 
 - 5060-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0013-7227 
<br/><br/><label>Standard No.: </label>10.1210/endo.140.11.7116  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acid Phosphatase--analysis<br/>Adipocytes--drug effects<br/>Animals<br/>Bone Marrow Cells--cytology<br/>Bone Resorption<br/>Calcitriol--pharmacology<br/>Cell Differentiation--drug effects<br/>Cells, Cultured<br/>Chromans--pharmacology<br/>Hypoglycemic Agents--pharmacology<br/>Interleukin-11--pharmacology<br/>Isoenzymes--analysis<br/>Mice<br/>Mice, Inbred ICR<br/>Osteoclasts--drug effects<br/>Parathyroid Hormone--pharmacology<br/>Pioglitazone<br/>Receptors, Cytoplasmic and Nuclear--physiology<br/>Rosiglitazone<br/>Tartrate-Resistant Acid Phosphatase<br/>Thiazoles--pharmacology<br/>Thiazolidinediones<br/>Transcription Factors--physiology<br/>Troglitazone